Prime Medicine director granted 75,000 stock options
Prime Medicine director and 10% owner Robert Nelsen received a stock option grant for 75,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Prime Medicine director and 10% owner Robert Nelsen received a stock option grant for 75,000 shares of Common Stock. The option has an exercise price of $3.06 per share and expires on June 5, 2036. According to the terms, all 75,000 underlying shares vest in full on the earlier of June 5, 2027 or the date of the next annual meeting of stockholders, assuming he continues to provide service to the company through that vesting date. This is a compensation-related award, not an open-market purchase or sale.
Insider Trade Summary
Grant/Award: 75,000 shares
Grant/Award
1 txn
Insider
NELSEN ROBERT
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 75,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 75,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2027 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
Option grant size: 75,000 options
Exercise price: $3.06 per share
Shares underlying options: 75,000 shares
+3 more
6 metrics
Option grant size
75,000 options
Stock Option (right to buy) on Common Stock
Exercise price
$3.06 per share
Conversion or exercise price of stock options
Shares underlying options
75,000 shares
Underlying Common Stock associated with the options
Total derivative holdings after grant
75,000 options
Total shares following transaction for this option award
Vesting date trigger
June 5, 2027
Full vesting or earlier at next annual stockholder meeting
Option expiration
June 5, 2036
Expiration date of the stock option grant
Key Terms
Stock Option (right to buy), Common Stock, exercise price, expiration date, +2 more
6 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: 3.0600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-05T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"shares subject to this option shall vest in full upon the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"the date of the next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Robert Nelsen report in this Form 4 for Prime Medicine (PRME)?
Robert Nelsen reported receiving a grant of stock options for 75,000 shares of Prime Medicine Common Stock. The options are compensation-related, not an open-market transaction, and give him the right to buy shares at a fixed exercise price in the future.
What is the exercise price of Robert Nelsen’s Prime Medicine (PRME) stock options?
The options have an exercise price of $3.06 per share. This means Nelsen can buy Prime Medicine Common Stock at $3.06 per share once the options vest and before they expire, regardless of the market price at that time.
When do Robert Nelsen’s Prime Medicine (PRME) stock options vest?
The options vest in full on the earlier of June 5, 2027 or the date of Prime Medicine’s next annual stockholder meeting. Vesting is contingent on Nelsen’s continuous service to the company through the applicable vesting date, as specified in the grant terms.
When do Robert Nelsen’s Prime Medicine (PRME) stock options expire?
The stock options expire on June 5, 2036. After this expiration date, any unexercised options become worthless, so Nelsen must exercise vested options before that date if he wants to purchase the underlying shares.
Is this Prime Medicine (PRME) Form 4 a stock purchase or a sale by Robert Nelsen?
The Form 4 reflects a grant of stock options to Robert Nelsen, not a purchase or sale in the open market. The transaction is coded as an award, giving him the right to buy shares later rather than immediately changing his shareholdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates